Ameritas Investment Partners, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,880
-53.9%
9,8030.0%0.00%
Q2 2023$12,744
-26.1%
9,8030.0%0.00%
-100.0%
Q1 2023$17,253
-48.8%
9,8030.0%0.00%0.0%
Q4 2022$33,722
-29.7%
9,8030.0%0.00%
-50.0%
Q3 2022$48,000
+20.0%
9,8030.0%0.00%0.0%
Q2 2022$40,000
-29.8%
9,8030.0%0.00%0.0%
Q1 2022$57,000
-23.0%
9,8030.0%0.00%0.0%
Q4 2021$74,000
-15.9%
9,8030.0%0.00%
-33.3%
Q3 2021$88,000
-24.8%
9,8030.0%0.00%
-25.0%
Q2 2021$117,000
-4.9%
9,8030.0%0.00%
-20.0%
Q1 2021$123,000
-19.6%
9,8030.0%0.01%
-28.6%
Q4 2020$153,000
+64.5%
9,8030.0%0.01%
+75.0%
Q3 2020$93,000
+5.7%
9,8030.0%0.00%0.0%
Q2 2020$88,000
+41.9%
9,8030.0%0.00%0.0%
Q1 2020$62,000
-24.4%
9,8030.0%0.00%0.0%
Q4 2019$82,000
-7.9%
9,8030.0%0.00%0.0%
Q3 2019$89,000
-16.0%
9,8030.0%0.00%
-20.0%
Q2 2019$106,000
+34.2%
9,803
+18.6%
0.01%
+25.0%
Q1 2019$79,000
-16.8%
8,2650.0%0.00%
-20.0%
Q4 2018$95,000
-32.1%
8,2650.0%0.01%
-16.7%
Q3 2018$140,000
+19.7%
8,2650.0%0.01%0.0%
Q2 2018$117,000
-12.7%
8,265
+17.0%
0.01%0.0%
Q1 2018$134,000
+15.5%
7,0670.0%0.01%
+20.0%
Q4 2017$116,000
+52.6%
7,067
+22.8%
0.01%
+25.0%
Q3 2017$76,000
+49.0%
5,7560.0%0.00%
+100.0%
Q2 2017$51,000
+70.0%
5,7560.0%0.00%
+100.0%
Q1 2017$30,0005,7560.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders